These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 24434538)
1. Connexin hemichannel and pannexin channel electrophysiology: how do they differ? Patel D; Zhang X; Veenstra RD FEBS Lett; 2014 Apr; 588(8):1372-8. PubMed ID: 24434538 [TBL] [Abstract][Full Text] [Related]
2. Emerging issues of connexin channels: biophysics fills the gap. Harris AL Q Rev Biophys; 2001 Aug; 34(3):325-472. PubMed ID: 11838236 [TBL] [Abstract][Full Text] [Related]
3. Activation, permeability, and inhibition of astrocytic and neuronal large pore (hemi)channels. Hansen DB; Ye ZC; Calloe K; Braunstein TH; Hofgaard JP; Ransom BR; Nielsen MS; MacAulay N J Biol Chem; 2014 Sep; 289(38):26058-26073. PubMed ID: 25086040 [TBL] [Abstract][Full Text] [Related]
4. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons. Bennett MV; Garré JM; Orellana JA; Bukauskas FF; Nedergaard M; Sáez JC Brain Res; 2012 Dec; 1487():3-15. PubMed ID: 22975435 [TBL] [Abstract][Full Text] [Related]
5. The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1. Wang J; Jackson DG; Dahl G J Gen Physiol; 2013 May; 141(5):649-56. PubMed ID: 23589583 [TBL] [Abstract][Full Text] [Related]
6. P2X7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization. Poornima V; Madhupriya M; Kootar S; Sujatha G; Kumar A; Bera AK J Mol Neurosci; 2012 Mar; 46(3):585-94. PubMed ID: 21932038 [TBL] [Abstract][Full Text] [Related]
8. At the cross-point of connexins, calcium, and ATP: blocking hemichannels inhibits vasoconstriction of rat small mesenteric arteries. Bol M; Wang N; De Bock M; Wacquier B; Decrock E; Gadicherla A; Decaluwé K; Vanheel B; van Rijen HV; Krysko DV; Bultynck G; Dupont G; Van de Voorde J; Leybaert L Cardiovasc Res; 2017 Feb; 113(2):195-206. PubMed ID: 27677282 [TBL] [Abstract][Full Text] [Related]
9. P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Iglesias R; Locovei S; Roque A; Alberto AP; Dahl G; Spray DC; Scemes E Am J Physiol Cell Physiol; 2008 Sep; 295(3):C752-60. PubMed ID: 18596211 [TBL] [Abstract][Full Text] [Related]
10. Is pannexin the pore associated with the P2X7 receptor? Alberto AV; Faria RX; Couto CG; Ferreira LG; Souza CA; Teixeira PC; Fróes MM; Alves LA Naunyn Schmiedebergs Arch Pharmacol; 2013 Sep; 386(9):775-87. PubMed ID: 23657251 [TBL] [Abstract][Full Text] [Related]
11. Distinct permeation profiles of the connexin 30 and 43 hemichannels. Hansen DB; Braunstein TH; Nielsen MS; MacAulay N FEBS Lett; 2014 Apr; 588(8):1446-57. PubMed ID: 24503060 [TBL] [Abstract][Full Text] [Related]
15. Regulation of connexin hemichannel activity by membrane potential and the extracellular calcium in health and disease. Fasciani I; Temperán A; Pérez-Atencio LF; Escudero A; Martínez-Montero P; Molano J; Gómez-Hernández JM; Paino CL; González-Nieto D; Barrio LC Neuropharmacology; 2013 Dec; 75():479-90. PubMed ID: 23587648 [TBL] [Abstract][Full Text] [Related]
16. Structural determinants underlying permeant discrimination of the Cx43 hemichannel. Nielsen BS; Zonta F; Farkas T; Litman T; Nielsen MS; MacAulay N J Biol Chem; 2019 Nov; 294(45):16789-16803. PubMed ID: 31554662 [TBL] [Abstract][Full Text] [Related]
17. Maxi-anion channel and pannexin 1 hemichannel constitute separate pathways for swelling-induced ATP release in murine L929 fibrosarcoma cells. Islam MR; Uramoto H; Okada T; Sabirov RZ; Okada Y Am J Physiol Cell Physiol; 2012 Nov; 303(9):C924-35. PubMed ID: 22785119 [TBL] [Abstract][Full Text] [Related]
18. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening. Wang N; De Bock M; Decrock E; Bol M; Gadicherla A; Bultynck G; Leybaert L Neuropharmacology; 2013 Dec; 75():506-16. PubMed ID: 24007825 [TBL] [Abstract][Full Text] [Related]
20. Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases. Mat Nor MN; Rupenthal ID; Green CR; Acosta ML Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]